BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32112078)

  • 21. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.
    Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X
    Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.
    Ureshino H; Murakami Y; Watari K; Izumi H; Kawahara A; Kage M; Arao T; Nishio K; Yanagihara K; Kinoshita H; Kuwano M; Ono M
    PLoS One; 2012; 7(7):e41312. PubMed ID: 22844455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma.
    Wei W; Bracher-Manecke JC; Zhao X; Davies NH; Zhou L; Ai R; Oliver L; Vallette F; Hendricks DT
    Cancer Biol Ther; 2013 Feb; 14(2):164-74. PubMed ID: 23192272
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Zhang J; Wu J; Chen Y; Zhang W
    Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
    Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
    Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
    Liu Z; Li H; Fan S; Lin H; Lian W
    Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma.
    Su W; Tang J; Wang Y; Sun S; Shen Y; Yang H
    J Cell Mol Med; 2019 Apr; 23(4):2645-2655. PubMed ID: 30677230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Kurehara H; Sugito N; Tomoda K; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
    Dis Esophagus; 2006; 19(6):454-8. PubMed ID: 17069588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
    J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
    Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
    Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
    Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
    Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
    Pramanik KK; Mishra R
    Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of IGFBP-2 in oral cancer metastasis.
    Tsai YF; Chou HC; Liou MH; Liao EC; Cheng CT; Chang SJ; Chan HL
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166143. PubMed ID: 33864954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
    Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
    Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratin 17 Is Induced in Oral Cancer and Facilitates Tumor Growth.
    Khanom R; Nguyen CT; Kayamori K; Zhao X; Morita K; Miki Y; Katsube K; Yamaguchi A; Sakamoto K
    PLoS One; 2016; 11(8):e0161163. PubMed ID: 27512993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.